Φορτώνει......
Market Share and Costs of Biologic Therapies for Inflammatory Bowel Disease in the United States
BACKGROUND: Real-world data quantifying the costs of increasing biologics use in inflammatory bowel disease (IBD) are unknown. AIM: To determine the outpatient IBD drug utilization trends, relative market share, and costs in the United States during a nine-year period. METHODS: The Truven MarketScan...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Aliment Pharmacol Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5760274/ https://ncbi.nlm.nih.gov/pubmed/29164650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14430 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|